Loading...
XSHE
000881
Market cap905mUSD
Oct 09, Last price  
6.51CNY
1D
1.56%
1Q
5.17%
Jan 2017
-76.15%
Name

CGN Nuclear Technology Development Co Ltd

Chart & performance

D1W1MN
XSHE:000881 chart
P/E
—
P/S
1.11
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-3.55%
Revenues
5.55b
-9.97%
2,131,102,7072,500,985,0761,701,080,7721,741,564,3791,722,175,4162,665,027,4281,997,645,3902,029,650,4402,136,512,2843,015,133,2616,363,194,3056,776,114,2267,021,621,5936,651,679,5906,651,679,5907,998,857,6826,944,907,1746,352,518,9436,168,400,5785,553,315,758
Net income
-287m
L-20.73%
126,628,407161,133,455110,385,152203,319,714230,026,051200,924,790108,354,52775,022,097245,402,565311,913,565388,861,599319,703,589102,681,779271,123,164271,123,171176,723,243199,594,594-737,163,925-362,167,590-287,093,833
CFO
138m
-69.79%
70,134,519185,648,730605,109,070140,773,096200,694,34649,320,402824,569,083435,411,6960340,111,23566,847,432225,074,306140,962,771728,864,340547,361,013475,720,066563,624,947371,271,537456,344,040137,865,441
Dividend
Jun 07, 20230.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services. In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products. Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.

Key people

Mingda Chen
Chief Accounting Officer, Chief Compliance Officer, General Counsel · since 2026
Gang Chen
General Counsel, Chief Economist
Xuefei Deng
Deputy General Manager · since 2018
Shiming Ma
Deputy General Manager · since 2024
Guoqing Tan
Deputy General Manager · since 2026
Xipo Wang
Deputy General Manager · since 2018
Bo Qin
Assistant General Manager · since 2023
Xinchun Yang
Secretary of the Board · since 2020
Fei He
Director · since 2025
Wenjun Mou
Director · since 2024
Changkun Mu
Director · since 2024
Guofu Sheng
Chairman of the Board, Acting General Manager, Acting Secretary of the Board · since 2025
Yuanming Wu
Director · since 2024
Haifeng Yu
Director · since 2025
Guangping Zheng
Director · since 2026
Xiaoyan Huang
Independent Director · since 2021
Xiaoyue Kang
Independent Director · since 2023
Man Wang
Independent Director · since 2025
IPO date
Sep 02, 1998
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
辽宁省大连市西岗区黄河路219号
大连市, LN 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122021‑002020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT